Clinical Trial Update: Exelon Patch and Combination With Memantine Comparative Trial [Phase 4]

View source ↗

Summary

Phase 4 comparative trial evaluating rivastigmine transdermal patch alone versus in combination with memantine for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Exelon Patch (rivastigmine transdermal patch)
• Memantine (memantine)

Snippet

Sponsor: Inha University Hospital | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED